Skip to main content

Spectrum: Autism Research News

Tag: treatments

January 2023
Research image showing neuronal activity in mice exposed to high-frequency sounds.

Missing mechanism helps solve fragile X protein mystery

by  /  24 January 2023

Cells from people with fragile X syndrome overproduce — but don’t accumulate — proteins. New work suggests that excessive protein breakdown may account for this discrepancy, and explain some of the syndrome’s traits.

Comments
Illustration of a signature being signed on a form.

Decisional capacity and informed consent, explained

by  /  23 January 2023

To include more autistic people in research, here’s what scientists need to know about informed consent procedures for study participants who have impaired decision-making capacity.

Comments
Illustration of hybrid objects: part light bulb, part lab vial, some in blue and some in red to signify null and replicated results.

Null & Noteworthy: Intervention flops; neural noise; gender care

by  /  18 January 2023

This edition takes aim at the autism-intervention evidence base with a slew of null results, plus findings that challenge a prevailing autism brain theory.

Comments
Headshots of Melissa Licari, Somer Bishop, Jana Iverson, Anjana Bhat and Audrey Thurm.

Should motor impairment be added to the diagnostic criteria for autism?

by  /  11 January 2023

In light of growing evidence that motor challenges are common among people with autism, we asked five researchers how these problems fit into the definition of the condition.

Comments
December 2022
Illustration of hybrid objects: part light bulb, part lab vial, some in blue and some in red to signify null and replicated results.

Null and Noteworthy: Reinforcing rigor; medication medley

by  /  14 December 2022

This month’s newsletter highlights findings on the use of three medication types during pregnancy.

Comments
lllustration of the junction between two nerve cells.

Multi-omics study captures CNTNAP2’s far-ranging effects

by  /  8 December 2022

The in-depth approach shows mutations in the autism-linked gene disrupt neuronal growth and communication, as well as mitochondrial gene expression.

Comments
October 2022

Beyond the bench: Mastering meaningful movement with Karen Chenausky

by  /  21 October 2022

The competitive rower-turned-researcher spoke to Spectrum about how trying out for the U.S. national rowing team and a subsequent coaching position shaped her study of speech development.

Comments
Jeremy Levin, chief executive officer of Ovid Therapeutics, stands against a bench in a lab.

What next for Angelman?

by  /  20 October 2022

A meeting in Texas reckons with the future of treatment, following two setbacks in 2020.

Comments
An illustration of a scientist sitting at a desk with abstract shapes representing ideas floating above her.

Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams

by  /  7 October 2022

The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.

Comments
September 2022

Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer

by  /  7 September 2022

Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.

Comments